hand-held

For Sophie, New Year’s Eve was as much an “I don’t have cancer anymore” party as it was a celebration of her 18 th birthday. To mark World Cancer Day , This Is Medtech shares Sophie’s tribute to 2016 and to life itself. “Cancer sucks. Everyone knows that. But believe it or not, even cancer has its silver lining,” she says of New Year’s Eve 2015/2016, which was the best night of her life thanks to Make-A-Wish Australia , a charity that grants wishes to children with life-threatening illnesses. 1 The evening of music and spectacular fireworks at the Lord Mayor’s New Year’s Eve party in Sydney marked a new beginning for Sophie, who was diagnosed at the age of 13 with Stage 4 medulloblastoma, a common type of childhood brain cancer. “I endured endless days in hospital beds undergoing chemo and radiation,” she says, adding that this gave her plenty of time to think about her wish. Brain cancer is the second most common type of cancer in children, followed by leukaemia, or cancer of the blood cells. According to the Children’s Cancer and Leukaemia Group in the UK, childhood cancers can be quite different from those affecting adults in that they tend to occur in different parts of the body and they respond differently to treatment. It’s encouraging to know that the survival rate for children’s cancer has more than doubled since the 1960s, and that about 82% of all children can now go into complete remission. For some children’s cancers, the remission rate is even higher. Everybody’s cancer story is unique Cancer treatment is individualised and therefore varies from patient to patient. However, the three main types of treatment are surgery, radiotherapy and chemotherapy. If the disease hasn’t spread to other parts of the body, surgery can...
2015 has been predicted, by many commentators, as the year that digital health will officially ‘’take off’’ due to increased consumer-wide acceptance, a growing array of digitally enabled health applications and increased investment levels. All of these factors are contributing to the cause for more and more leading consumer brands to enter into the digital health space, as product innovation and business growth opportunities present themselves accordingly. The FT Digital Health SummitEurope is bringing together leaders from all parts of the healthcare industry to assess the uptake and advancement of healthcare's digital transformation. With executive leaders from Janssen, Sanofi, Boehringer Ingelheim, GSK and Bayer all speaking at the event you will gain insight into how these pharma companies are prioritising their digital strategies. You will also be able to assess how digital innovations can be incorporated into the everyday doctor-patient relationship through a unique panel discussion exclusively involving Chief Medical Officers . Investment in this sector is of course critical for its success so a diverse panel involving speakers from investment banking, private equity and venture capital will discuss the opportunities as well as the risks in financing digital health. Alongside this, speakers from the likes of Genomics England, the NHS and the European Commission will analyse the regulatory challenges that along with investment formats, form the basis of success in digital health business models and consumer acceptance. What can be done then? Building on the Financial Times’ expertise and coverage of health, life science and digital business, the FT Digital Health Summit Europe will bring together stakeholders from across the healthcare ecosystem – payers, providers, technology, data and life science companies as well as financiers, to bring unique focus and insight into the commercial, economical and regulatory challenges that healthcare’s digital transformation faces when it looks to finally ‘’take...